HealthDay News — Individuals with hypertension are unlikely to measure their blood pressure (BP) at home as often as ...

No increased risk for death, acute neurosurgical operations, or length of hospitalization seen in association with ...

HealthDay News — Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of ...

HealthDay News — A fast-growing measles outbreak in South Carolina has eclipsed last year’s record-setting Texas surge. As of ...

AAP maintains routine vaccine recs despite CDC changes; FDA warns of serious injury with wound and burn products; subcutaneous Alzheimer disease treatment under review; Cardamyst nasal spray available ...

Topline results show eDSP failed to significantly improve RmICARS scores in ataxia-telangiectasia patients compared with placebo in the NEAT trial.

The Food and Drug Administration (FDA) has granted Fast Track designation to QTX-2101, an oral formulation of arsenic trioxide, for the treatment of acute promyelocytic leukemia (APL), an aggressive ...

The researchers found that patients taking GLP-1 RAs had a significantly reduced incidence of revision FESS versus the non-GLP-1 RA group at one-year (risk ratio [RR], 0.64) and five-year follow-up ...

Yuvezzi, a combination cholinergic agonist and alpha-adrenergic agonist, is now FDA-approved as a once-daily treatment for ...

HealthDay News — More than 31,000 nurses and health care workers walked off the job Monday morning at Kaiser Permanente ...

Ivonescimab is a first-in-class, investigational bispecific antibody targeting programmed cell death protein 1 and vascular endothelial growth factor.

HealthDay News — For the 5 leading causes of cancer-related death in people younger than 50 years, mortality decreased from 1990 through 2023, except for colorectal cancer (CRC), according to a ...